Product name: NY-ESO-1(157-165)

Sequence: SLLMWITQC

Purity: 95% by HPLC

Counter ion: Trifluoacetate

Format: Lyophilized powder

Description: The NY-ESO-1 antigen is a classic CT antigen initially identified by SEREX (serological analysis of recombinant cDNA expression) analysis of an esophageal cancer patient and then found to be expressed in a variable proportion of a wide range of different tumor types, including melanoma, breast, ovary, and lung cancers. The cancer-testis antigen NY-ESO-1 is one of the most promising candidates for generic vaccination of cancer patients.

Uniprot ID: P78358

Usage: For Scientific Research Use Only, Not for Human Use.

Reference:

Cancer Immunol Res January 2014 2; 37.

J Clin Invest. 2002;110(12):1813–1822.